University Education: Pharm D
Post Doctoral Studies:
1974-1976, London Hospital Medical Colledge (London, UK)
1957-1962, School of Pharmacy (Tehran University)
Scholarship:
1974-1976 British Council Post Doctoral Scholarship
Professional and Teaching Experience:
2004- Professor of Institute for Addiction Studies
(Tehran University of Medical Sciences)
2004- Adjunct Professor of International Biophysics &
Biochemistry
2000- present Associate member of Academy of Medical
Sciences
1999- Present Editor of Archives Iranian Medicine
1992-1994 Head of Department of Pharmacology, School of
Medicine (Tehran Univ of Med Sci)
1985-Present Professor of Pharmacology (Department of
Pharmacology, School of Medicine (Tehran Univ of Med Sci)
1984-90 Editor (Journal of School of Med, Tehran Univ
of Med Sci)
1982-84 Head of Dept. Pharmacol (Department of
Pharmacology, School of Medicine (Tehran Univ of Med Sci)
1974-85 Associate Professor, Dept Pharmacol (Tehran
Univ Med Sci)
1965-69 Assistant Dept pharmacol (Tehran Univ
Med Sci)
Research field: Neuropharmacology
Publications:
1:
Sahraei H, Poorheidari G, Foadaddini M, Khoshbaten A,
Asgari A, Noroozzadeh A, Ghoshooni H, Firoozabadi SH,
Zarrindast MR.
Effects of nitric oxide on morphine
self-administration in rat.
Pharmacol Biochem Behav.
2004 Jan; 77(1): 111-6.
2:
Zarrindast MR, Gholami A, Sahraei H, Haeri-Rohani A.
Role of nitric oxide in the acquisition and expression
of apomorphine- or morphine-induced locomotor
sensitization. Eur J
Pharmacol. 2003 Dec 15; 482(1-3): 205-13.
3:
Zarrindast MR, Baghdadi B, Sahebgharani M.
Potentiation of imipramine-induced antinociception by
nicotine in the formalin test.
Eur Neuropsychopharmacol.
2004 Jan; 14(1): 71-6.
4:
Zarrindast MR, Shamsi T, Azarmina P, Rostami P, Shafaghi
B.
GABAergic system and imipramine-induced impairment of
memory retention in rats.
Eur Neuropsychopharmacol. 2004 Jan; 14(1): 59-64.
5:
Zarrindast MR, Torkaman-Boutorabi A.
Effects of imipramine on the expression and
development of morphine dependence in mice.
Eur J Pharmacol. 2003 Jul
18; 473(1): 19-25.
6:
Zarrindast MR, Sadeghi S, Sahebgharani M.
Influence of alpha-adrenoceptor agonists and
antagonists on imipramine-induced hypothermia in mice.
Pharmacol Toxicol. 2003
Jul; 93(1): 48-53.
7:
Zarrindast MR, Assadi E, Oryan S, Torkaman-Boutorabi A,
Sahebgharani M.
Influence of histamine, cimetidine and pyrilamine on
naloxone-induced jumping in morphine-dependent mice. ]Jur
J Pharmacol. 2003 Jun 20; 471(2): 105-12.
8:
Zarrindast MR, Vousooghi N, Sahebgharani M.
Imipramine-induced antinociception in the formalin
test. Receptor mechanisms involved and effect of swim
stress. Pharmacology.
2003 Jul; 68(3): 154-61.
9:
Karami M, Zarrindast MR, Sepehri H, Sahraei H.
Sulpiride injections into the
medial septum reverse the influence of intra-medial
septum injection of L-arginine on expression of place
conditioning-induced by morphine in rats.
Brain Res. 2003 Jun 20;
976(1): 30-40.
10:
Fazli-Tabaei S, Fahim M, Zarrindast MR.
Effect of acute and chronic lead exposure on apomorpine-induced sniffing in rats.Pharmacol
Toxicol. 2003 Feb; 92(2): 88-93.
11:
Zarrindast MR, Matinrokh H, Mojtahedzadeh-Ardebili P.
Adenosine receptor agonists or antagonists alter antinociception, but did not show an interaction with
imipramine-induced antinociception in the formalin test
in mice. Eur
Neuropsychopharmacol. 2003 May; 13(3): 165-72.
12:
Zarrindast MR, Ghiasvand M, Homayoun H, Rostami P,
Shafaghi B, Khavandgar S.
Adrenoceptor mechanisms underlying imipramine-induced
memory deficits in rats.
J Psychopharmacol. 2003 Mar; 17(1): 83-8.
13:
Khavandgar S, Homayoun H, Zarrindast MR.
The effect of L-NAME and L-arginine on
impairment of memory formation and state-dependent
learning induced by morphine in mice.
Psychopharmacology (Berl).
2003 May; 167(3): 291-6. Epub 2003 Mar 28.
14:
Eidi M, Zarrindast MR, Eidi A, Oryan S, Parivar K.
Effects of histamine and cholinergic systems on
memory retention of passive avoidance learning in rats.
Eur J Pharmacol. 2003 Mar
28; 465(1-2): 91-6.
15:
Zarrindast MR, Rezayof A, Sahraei H, Haeri-Rohani A,
Rassouli Y.
Involvement of dopamine D1 receptors of the central amygdala on the acquisition and expression of
morphine-induced place preference in rat.
Brain Res. 2003 Mar 7;
965(1-2): 212-21.
16:
Homayoun H, Khavandgar S, Zarrindast MR.
Morphine state-dependent learning: interactions with
alpha2-adrenoceptors and acute stress.
Behav Pharmacol. 2003
Feb; 14(1): 41-8.
17:
Zarrindast MR, Bakhsha A, Rostami P, Shafaghi B.
Effects of intrahippocampal injection of GABAergic
drugs on memory retention of passive avoidance learning
in rats.
J Psychopharmacol. 2002
Dec; 16(4): 313-9.
18:
Gholami A, Zarrindast MR, Sahraei H, Haerri-Rohani A.
Nitric oxide within the ventral tegmental area is
involved in mediating morphine reward.
Eur J Pharmacol. 2003 Jan
1; 458(1-2): 119-28.
19:
Zarrindast MR, Faraji N, Rostami P, Sahraei H, Ghoshouni
H.
Cross-tolerance between morphine- and
nicotine-induced conditioned place preference in mice.
Pharmacol Biochem Behav.
2003 Jan; 74(2): 363-9.
20:
Khavandgar S, Homayoun H, Torkaman-Boutorabi A,
Zarrindast MR.
The effects of adenosine receptor agonists and
antagonists on morphine state-dependent memory of
passive avoidance.
Neurobiol Learn Mem. 2002 Sep; 78(2): 390-405.
21:
Fazli-Tabaei S, Yahyavi SH, Zarrindast MR.
Effects of lithium carbonate on apomorphine-induced
sniffing behaviour in rats.
Pharmacol Toxicol. 2002
Sep; 91(3): 135-9.
22:
Zarrindast MR, Ahmadi R, Oryan S, Parivar K,
Haeri-Rohani A.
Effects of alpha-adrenoceptor agonists and
antagonists on histamine-induced impairment of memory
retention of passive avoidance learning in rats.
Eur J Pharmacol. 2002 Nov
15; 454(2-3): 193-8.
23:
Zarrindast MR, Karami M, Sepehri H, Sahraei H.
Influence of nitric oxide on morphine-induced
conditioned place preference in the rat central amygdala.
Eur J Pharmacol. 2002 Oct
18; 453(1): 81-9.
24:
Rezayof A, Zarrindast MR, Sahraei H, Haeri-Rohani AH.
Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of
morphine-induced place preference in rat.
Pharmacol Biochem Behav.
2002 Dec; 74(1): 187-97.
25:
Zarrindast MR, Hadi M, Homayoun H, Postami P, Shafaghi
B, Khavandgar S.
The role of alpha-adrenoceptors in the
amnestic effect of intracerebroventricular dexamethasone.
Pharmacol Res. 2002 Oct;
46(4): 339-44.
26:
Zarrindast MR, Eidi M, Eidi A, Oryan S.
Effects of histamine and opioid systems on memory
retention of passive avoidance learning in rats.
Eur J Pharmacol. 2002 Oct
4; 452(2): 193-7.
27:
Zarrindast MR, Habibi M, Borzabadi S, Fazli-Tabaei S,
Hossein Yahyavi S, Rostamin P.
The effects of dopamine receptor agents on naloxone-induced
jumping behaviour in morphine-dependent mice.
ur J Pharmacol. 2002 Sep
20; 451(3): 287-93.
28:
Zarrindast MR, Dinkoub Z, Homayoun H, Bakhtiarian A,
Khavandgar S.
Dopamine
receptor mechanism(s) and morphine tolerance in mice.
J Psychopharmacol. 2002 Sep; 16(3): 261-6.
29:
Zarrindast MR, Adl M, Sharifzadeh M, Bahreini T.
Role of nitric oxide in systemic effect of theophylline on mouse body temperature.
ur J Pharmacol. 2002 Sep
6; 451(1): 63-8.
30:
Zarrindast MR, Bahreini T, Adl M.
Effect of imipramine on the expression and
acquisition of morphine-induced conditioned place
preference in mice. Parmacol
Biochem Behav. 2002 Nov; 73(4): 941-9.
31:
Gholami A, Haeri-Rohani A, Sahraie H, Zarrindast MR.
itric oxide mediation of morphine-induced place
preference in the nucleus accumbens of rat. Eur
J Pharmacol. 2002 Aug 9; 449(3): 269-77.
32:
arami M, Zarrindast MR, Sepehri H, Sahraei.
Role of nitric oxide in the rat hippocampal CA1
area on morphine-induced conditioned place
preference. Eur J
Pharmacol. 2002 Aug 2; 449(1-2): 113-9.
33:
Zarrindast MR, Homayoun H, Khavandgar S, Fayaz-Dastgerdi
M, Fayaz-Dastgerdi M.
The effects of simultaneous administration of
alpha(2) -adrenergic agents with L-NAME or L-arginine on
the development and expression of morphine dependence in
mice. Behav Pharmacol.
2002 Mar; 13(2): 117-25.
34:
Mahmoudi M, Zarrindast MR.
Effect of intracerebroventricular injection of GABA
receptor agents on morphine-induced antinociception in
the formalin test.
J
Psychopharmacol. 2002 Mar; 16(1): 85-91.
35:
Zarrindast MR, Ramezani-Tehrani B, Ghadimi M.
Effects of adrenoceptor agonists and antagonists on
morphine-induced Straub tail in mice.
Pharmacol Biochem Behav.
2002 May; 72(1-2): 203-7.
36:
Zarrindast MR, Samadi P, Haeri-Rohani A, Moazami N,
Shafizadeh M.
Nicotine potentiation of morphine-induced catalepsy
in mice.
Pharmacol Biochem Behav.
2002 May; 72(1-2): 197-202.
37:
Zarrindast MR, Sahebgharani M.
Effect of alpha-adrenoceptor agonists and antagonists on
imipramine-induced antinociception in the rat formalin
test. Pharmacology. 2002
Apr; 64(4): 201-7.
38:
Matloubi H, Ghandi M, Zarrindast MR, Saemian N.
Modified synthesis of 11-[14C]-clozapine.
Appl Radiat Isot. 2001
Dec; 55(6): 789-91.
39:
Homayoun H, Khavandgar S, Zarrindast MR.
Effects of adenosine receptor agonists and antagonists
on pentylenetetrazole-induced amnesia.
Eur J Pharmacol. 2001 Nov
2; 430(2-3): 289-94.
40:
Zarrindast MR, Mahmoudi M.
GABA mechanisms and antinociception in mice with ligated
sciatic nerve.
Pharmacol Toxicol. 2001
Aug; 89(2): 79-84.
41:
Zarrindast MR, Alaei-Nia K, Shafizadeh M.
On the mechanism of tolerance to morphine-induced Straub
tail reaction in mice.
Pharmacol Biochem Behav. 2001 Jul-Aug; 69(3-4): 419-24.
42:
Zarrindast M, Rostami P, Sadeghi-Hariri M.
GABA(A) but not GABA(B) receptor stimulation induces
antianxiety profile in rats.
Pharmacol Biochem Behav.
2001 May-Jun; 69(1-2): 9-15.
43:
Sahebgharani M, Zarrindast M.
Effect of alpha-adrenoceptor agents on imipramine-induced
antinociception in nerve-ligated mice.
Eur Neuropsychopharmacol.
2001 Apr; 11(2): 99-104.
44:
Zarrindast MR, Barghi-Lashkari S, Shafizadeh M.
The possible cross-tolerance between morphine- and
nicotine-induced hypothermia in mice.
Pharmacol Biochem Behav. 2001 Feb; 68(2): 283-9.
45:
Zarrindast MR, Khodjastehfar E, Oryan S,
Torkaman-Boutorabi A.
Baclofen-impairment of memory retention in rats:
possible interaction with adrenoceptor mechanism(s).
Eur J Pharmacol. 2001 Jan
12; 411(3): 283-8.
46:
Zarrindast MR, Samiee F, Rezayat M.
Antinociceptive effect of intracerebroventricular
administration of cholecystokinin antagonist in nerve-ligated
mice.
Pharmacol Toxicol. 2000
Oct; 87(4): 169-73.
47:
Zarrindast MR, Shaverdian S, Sahebgharani M.
Effect of imipramine on tolerance to morphine
antinociception in the formalin test.
Pharmacol Toxicol. 2000
Sep; 87(3): 131-7.
48:
Zarrindast MR, Homayoun H, Babaie A, Etminani A, Gharib
B.
Involvement of adrenergic and cholinergic systems in
nicotine-induced anxiogenesis in mice.
Eur J Pharmacol. 2000 Oct
27; 407(1-2): 145-58.
49:
Zarrindast M, Valizadeh S, Sahebgharani M.
GABA(B) receptor mechanism and imipramine-induced
antinociception in ligated and non-ligated mice.
Eur J Pharmacol. 2000 Oct
27; 407(1-2): 65-72.
50:
Rezayat M, Rahnavard A, Zarrindast MR.
Role of cholecystokinin receptors in induction of
antinociception in hot-plate test.
Pharmacol Toxicol. 2000
Aug; 87(2): 58-62.
51:
Zarrindast MR, Mohaddess G, Rezvani-Pour M.
Effect of nicotine on sniffing induced by dopaminergic receptor stimulation.
Eur Neuropsychopharmacol.
2000 Sep; 10(5): 397-400.
52:
Zarrindast MR, Haeri-Zadeh F, Zarghi A, Lahiji P.
Nicotine potentiates sulpiride-induced catalepsy in
mice.
J Psychopharmacol. 1998;
12(3): 279-82.
53:
Zarrindast MR, Fazli-Tabaei S, Semnanian S, Fathollah Y,
Yahyavi SH.
Effects of adrenoceptor agents on apomorphine-induced
licking behavior in rats.
Pharmacol Biochem Behav. 2000 Feb; 65(2): 275-9.
54:
Tabatabai SA, Zarrindast MR, Lashkari SB, Shafiee A.
Synthesis, conformational analysis and antinociceptive activity of
1-[N-methyl-(2-phenylethyl)amino]methyl-1,2,3,4-tetrahydroisoquinoline
derivatives.
Arzneimittelforschung.
1999 Dec; 49(12): 1001-5.
55:
Sabetkasai M, Ahang S, Shafaghi B, Zarrindast MR.
Baclofen-induced antinociception and nicotinic
receptor mechanism(s).
Pharmacol Toxicol. 1999
Nov; 85(5): 247-51.
56:
Sahraei H, Motamedi F, Khoshbaten A, Zarrindast MR.
Adenosine A(2) receptors inhibit morphine
self-administration in rats.
Eur J Pharmacol. 1999 Oct
27; 383(2): 107-13.
57:
Zarrindast MR, Mousa-Ahmadi E.
Effects of GABAergic system on naloxone-induced
jumping in morphine-dependent mice.
Eur J Pharmacol. 1999 Sep
24; 381(2-3): 129-33.
58:
Zarrindast MR, Nassiri-Rad S, Pazouki M.
Effects of dopaminergic agents on antinociception in
formalin test.
Gen Pharmacol. 1999 Apr;
32(4): 517-22.
59:
Sabetkasai M, Khansefid N, Yahyavi SH, Zarrindast MR
Baclofen and antidepressant--induced antinociception
in formalin test: possible GABA(B) mechanism
involvement.
Psychopharmacology (Berl). 1999 Mar; 142(4): 426-31.
60:
Zarrindast MR, Shekarchi M, Rezayat M.
Effect of nicotine on apomorphine-induced licking
behaviour in rats.
Eur Neuropsychopharmacol.
1999 Mar; 9(3): 235-8.
61:
Zarrindast MR, Khoshayand MR, Shafaghi B.
The development of cross-tolerance between morphine
and nicotine in mice.
Eur Neuropsychopharmacol.
1999 Mar; 9(3): 227-33.
62:
Rezayat M, Ravandeh N, Zarrindast MR.
Cholecystokinin and morphine-induced hypothermia.
Eur Neuropsychopharmacol.
1999 Mar; 9(3): 219-25.
63:
Zarrindast MR, Naghipour B, Roushan-zamir F, Shafaghi B.
Effects of adenosine receptor agents on the
expression of morphine withdrawal in mice.
Eur J Pharmacol. 1999 Mar
12; 369(1): 17-22.
64:
Rezayat M, Tabarrai E, Parvini S, Zarrindast MR, Pirali
M.
Effects of CCK antagonists on GABA mechanism-induced
antinociception in the formalin test.
Eur Neuropsychopharmacol. 1999 Jan; 9(1-2): 9-14.
65:
Zarrindast MR, Sedaghati F, Borzouyeh F.
Nicotine-induced grooming: a possible dopaminergic
and/or cholinergic mechanism.
J Psychopharmacol. 1998;
12(4): 375-9.
66:
Zarrindast MR, Nikfar S, Rezayat M.
Cholecystokinin receptor mechanism(s) and morphine
tolerance in mice.
Pharmacol Toxicol. 1999
Jan; 84(1): 46-50.
67:
Zarrindast MR, Fazli-Tabai S, Semnanian S, Fathollahi Y.
Influence of different adrenoceptor agonists and
antagonists on physostigmine-induced yawning in rats.
Pharmacol Biochem Behav.
1999 Jan; 62(1): 1-5.
68:
Zarrindast MR, Rezayat M, Ghanipoor N, Parvini S.
Interactions between antinociception induced by
cholecystokinin antagonists and GABA agonists in the
tail-flick test.
Pharmacol Toxicol. 1998 Oct; 83(4): 143-8.
69:
Ghazi-Khansari M, Rezvani N, Bani-Assadi S, Zarrindast
MR.
Effects of lead exposure on licking and yawning behaviour in rats.
Pharmacol Toxicol. 1998
Sep; 83(3): 120-4.
70:
Zarrindast MR, Lahiji P, Shafaghi B, Sadegh M.
Effects of GABAergic drugs on physostigmine-induced
improvement in memory acquisition of passive avoidance
learning in mice.
Gen Pharmacol. 1998 Jul;
31(1): 81-6.
71:
Zarrindast MR, Iraie F, Heidari MR, Mohagheghi-Badi M.
Effect of adenosine receptor agonists and
antagonists on morphine-induced catalepsy in mice.
Eur J Pharmacol. 1997 Oct
29; 338(1): 11-6.
72:
Zarrindast MR, Pazouki M, Nassiri-Rad S.
Involvement of cholinergic and opioid receptor
mechanisms in nicotine-induced antinociception.
Pharmacol Toxicol. 1997
Nov; 81(5): 209-13.
73:
Rezayat M, Azizi N, Zarrindast MR.
On the mechanism(s) of cholecystokinin (CCK):
receptor stimulation attenuates morphine dependence in
mice.
Pharmacol Toxicol.
1997 Sep; 81(3): 124-9.
74:
Sawynok J, Zarrindast MR,
Reid AR, Doak G
Adenosine A3 receptor activation produces
nociceptive behaviour and edema by release of histamine
and 5-hydroxytryptamine.
Eur J Pharmacol. 1997 Aug
20; 333(1): 1-7.
75:
Ghazi-Khansari M, Heidari I, Zarrindast MR
Effects of lead exposure on bromocriptine-induced
penile erection in rats.
Pharmacol Toxicol. 1997 Aug; 81(2): 81-4.
76:
Zarrindast MR, Zabihi A, Rezayat M, Rakhshandeh H,
Ghazi-Khansari M, Hosseini R.
Effects of caerulein and CCK antagonists on
tolerance induced to morphine antinociception in mice.
Pharmacol Biochem Behav.
1997 Sep; 58(1): 173-8.
77:
Zarrindast MR,
Moghadamnia
Adenosine receptor agents and conditioned place
preference.
Gen Pharmacol. 1997 Aug;
29(2): 285-9.
78:
Shafizadeh M, Semnanian S, Zarrindast MR, Hashemi B.
Involvement of GABAB receptors in the
antinociception induced by baclofen in the formalin
test.
Gen Pharmacol. 1997
Apr; 28(4): 611-5.
79:
Zarrindast
MR, Oveisi MR.
Effects of monoamine receptor antagonists on
nicotine-induced hypophagia in the rat.
Eur J Pharmacol. 1997 Feb
26; 321(2): 157-62.
80:
Rezayat M, Oreizi S, Zarrindast MR.
Caerulein may potentiate morphine-induced
antinociception by cholecystokinin-A and/or
cholecystokinin-B receptor mechanisms.
Gen Pharmacol. 1997 Feb;
28(2): 337-40.
81:
Sabetkasai M, Doost-Mohammady R, Zarrindast MR.
Opposite influences of different adrenoceptors on
baclofen-induced antinociception in mice.
Pharmacol Toxicol. 1997
Jan; 80(1): 6-10.
82:
Zarrindast MR, Hodjati MR, Pejhan A, Soleimannejad E.
Bupropion induces sniffing: a possible dopaminergic
mechanism.
Eur Neuropsychopharmacol.
1996 Nov; 6(4): 299-303.
83:
Rashidy-Pour A, Motamedi F, Semnanian S, Zarrindast MR,
Fatollahi Y, Behzadi G.
Effects of
reversible inactivation of the medial septal area on
long-term potentiation and recurrent inhibition of
hippocampal population spikes in rats.
Brain Res. 1996 Sep 23; 734(1-2): 43-8.
84:
Zarrindast MR, Sharifzadeh M, Sadeghi AI.
Theophylline-induced
grooming: possible indirect dopaminergic mechanism.
Eur J Pharmacol. 1996 Jun
13; 306(1-3): 1-4.
85:
Zarrindast MR, Nami AB, Farzin D.
Nicotine
potentiates morphine antinociception: a possible
cholinergic mechanism.
Eur Neuropsychopharmacol. 1996 May; 6(2): 127-33.
86:
Heidari MR, Khalili F, Ghazi-khansari M, Hashemi B,
Zarrindast MR.
Effect of
picrotoxin on antinociception in the formalin test.
Pharmacol Toxicol. 1996
May; 78(5): 313-6.
87:
Zarrindast MR, Farzin D.
Nicotine attenuates naloxone-induced jumping
behaviour in morphine-dependent mice.
Eur J Pharmacol. 1996 Feb
29; 298(1): 1-6.
88:
Zarrindast MR, Sadegh M, Shafaghi B.
Effects of nicotine
on memory retrieval in mice.
Eur J Pharmacol. 1996 Jan
4; 295(1): 1-6.
89:
Zarrindast MR, Malekzadeh A, Rezayat M, Ghazi-Khansari
M.
Effects of
cholecystokinin receptor agonist and antagonists on
morphine dependence in mice.
Pharmacol Toxicol. 1995
Dec; 77(6): 360-4.
90:
Zarrindast MR, Jamali-Raeufy N, Shafaghi B.
Effects of high doses of theophylline on memory
acquisition.
Psychopharmacology (Berl).
1995 Dec; 122(3): 307-11.
91:
Zarrindast MR, Toloui V, Hashemi B.
Effects of
GABAergic drugs on physostigmine-induced yawning in
rats.
Psychopharmacology (Berl).
1995 Dec; 122(3): 297-300.
92:
Zarrindast MR, Fatehi F, Mohagheghi-Badi M.
Effects of
adenosine agents on apomorphine-induced yawning in rats.
Psychopharmacology (Berl).
1995 Dec; 122(3): 292-6.
93:
Sharifzadeh M, Zarrindast MR, Samini M.
Effects of
adenosine analogues on apomorphine-induced penile
erection in rats. Gen
Pharmacol. 1995 Dec; 26(8): 1785-90.
94:
Zarrindast MR, Sharifzadeh M.
Effects of
adenosine drugs on apomorphine-induced licking in rats.
Gen Pharmacol. 1995 Sep;
26(5): 1119-23.
95:
Zarrindast MR, Adeli R, Hosseini-semnani S, Sharifzadeh
M.
Effects of
adenosine receptor agonists and antagonists on
physostigmine-induced yawning.
Eur J Pharmacol. 1995 Mar
24; 276(1-2): 3-7.
96:
Zarrindast MR, Sajedian M, Rezayat M, Ghazi-Khansari M.
Effects of 5-HT
receptor antagonists on morphine-induced tolerance in
mice. Eur J Pharmacol.
1995 Feb 6; 273(3): 203-7.
97:
Zarrindast MR, Mamanpush SM, Rashidy-Pour A.
Morphine inhibits
dopaminergic and cholinergic induced ejaculation in
rats. Gen Pharmacol. 1994
Jul; 25(4): 803-8.
98:
Zarrindast MR, Farahvash H.
Effects of
GABA-ergic drugs on penile erection induced by
apomorphine in rats.
Psychopharmacology (Berl). 1994 Jun; 115(1-2): 249-53.
99:
Zarrindast MR, Heidari MR.
On the mechanisms
by which theophylline changes core body temperature in
mice. Eur J Pharmacol.
1994 May 12; 257(1-2): 13-20.
100:
Zarrindast MR, Shafaghi B.
Effects of
adenosine receptor agonists and antagonists on
acquisition of passive avoidance learning.
Eur J Pharmacol. 1994 May
2; 256(3): 233-9.
101:
Rezayat M, Nikfar S, Zarrindast MR.
CCK receptor
activation may prevent tolerance to morphine in mice.
Eur J Pharmacol. 1994 Mar
11; 254(1-2): 21-6.
102:
Zarrindast MR, Rezayat M.
Caerulein changes morphine-induced antinociception
depending on pretreatment times.
Gen Pharmacol. 1994 Mar;
25(2): 311-6.
103:
Zarrindast MR, Nikfar S.
Different
influences of adenosine receptor agonists and
antagonists on morphine antinociception in mice.
en Pharmacol. 1994 Jan;
25(1): 139-42.
104:
Zarrindast MR, Sabetkasai M, Khakpour S.
Effects of drugs active at adenosine receptors on
stress-induced analgesia in mice.
rch Int Pharmacodyn Ther.
1993 Sep-Oct; 325: 51-60.
105:
Sabetkasai M, Zarrindast MR.
ntinociception:
interaction between adenosine and GABA systems.
Arch Int Pharmacodyn Ther.
1993 Mar-Apr; 322: 14-22.
106:
Zarrindast MR, Bayat A, Shafaghi B.
Involvement of
dopaminergic receptor subtypes in straub tail behaviour
in mice. en Pharmacol.
1993 Jan; 24(1): 127-30.
107:
Motamedi F, Rashidy-Pour A, Zarrindast MR, Badavi M.
Bombesin-induced
anorexia requires central bombesin receptor activation:
independence from interaction with central
catecholaminergic systems.
Psychopharmacology (Berl).
1993; 110(1-2): 193-7.
108:
Zarrindast MR, Modabber M, Sabetkasai M.
Influences of
different adenosine receptor subtypes on catalepsy in
mice. Pychopharmacology (Berl).
1993; 113(2): 257-61.
109:
Zarrindast MR, Zarghi A.
Morphine
stimulates locomotor activity by an indirect
dopaminergic mechanism: possible D-1 and D-2 receptor
involvement.
Gen Pharmacol. 1992 Nov;
23(6): 1221-5.
110:
Zarrindast MR, Moini-Zanjani T, Manaheji H, Fathi F.
Influences of dopamine receptors on chewing
behaviour in rats.
Gen Pharmacol. 1992 Sep;
23(5): 915-9.
111:
Zarrindast MR, Sabetkasai M.
Stress-induced
antinociception and GABAergic mechanism.
Arch Int Pharmacodyn Ther.
1992 Jul-Aug; 318: 5-12.
112:
Zarrindast MR, Shokravi S, Samini M.
Opposite
influences of dopaminergic receptor subtypes on penile
erection. Gen Pharmacol.
1992 Jul; 23(4): 671-5.
113:
Zarrindast MR, Namdari S.
Ephedrine and amphetamine induced pecking in
chickens: possible indirect D-1/D-2 dopaminergic
mechanism.
Eur
Neuropsychopharmacol. 1992 Jun; 2(2): 135-40.
114:
Zarrindast MR, Hajian-Heydari A, Hoseini-Nia T.
Characterization of dopamine receptors involved in apomorphine-induced pecking in pigeons.
Gen Pharmacol. 1992 May; 23(3): 427-30.
115:
Zarrindast MR,
Jamshidzadeh A.
Inhibitory effect
of morphine on yawning induced by cholinoceptor and
dopamine D2 receptor activation in rats.
Br J Pharmacol. 1992 Mar;
105(3): 675-8.
116:
Zarrindast MR, Tabatabai SA.
Involvement of dopamine receptor subtypes in mouse
thermoregulation.
Psychopharmacology (Berl).
1992; 107(2-3): 341-6.
117:
Zarrindast MR, Abolfathi-Araghi F.
Effects of
bupropion on core body temperature of mice.
Psychopharmacology (Berl).
1992; 106(2): 248-52.
118:
Zarrindast MR, Amin R.
Role of D-1 and
D-2 receptors in apomorphine-induced pecking in chicks.
Psychopharmacology (Berl).
1992; 106(1): 67-70.
119:
Zarrindast MR, Nasir T.
Methylxanthine-induced
attenuation of pecking in chickens.
Br J Pharmacol. 1991 Oct;
104(2): 327-30.
120:
Zarrindast MR, Eliassi A.
Differential
effects of dopamine agonists on locomotion in intact and
reserpine-treated mice.
Gen Pharmacol. 1991; 22(6): 1027-31.
121:
Zarrindast MR, Habibi-Moini S.
Blockade of both
D-1 and D-2 dopamine receptors may induce catalepsy in
mice. Gen Pharmacol.
1991; 22(6): 1023-6.
122:
Zarrindast MR, Minaian A.
Different effects
of direct and indirect dopamine receptor agonists on
immobility time in reserpine-treated mice.
Gen Pharmacol. 1991;
22(6): 1017-21.
123:
Zarrindast MR, Owji AA, Hosseini-Nia T.
Evaluation of
dopamine receptor involvement in rat feeding behaviour.
Gen Pharmacol. 1991;
22(6): 1011-6.
124:
Zarrindast MR, Moghaddampour E.
Influences of
dopamine agonists and antagonists of baclofen
antinociception in mice.
Arch Int Pharmacodyn Ther. 1991 Jan-Feb; 309:
42-50.
125:
Zarrindast MR, Shahed-Dirin K.
Bromocriptine induces climbing behaviour: possible
D-1 or D-2 dopamine receptor involvement.
Psychopharmacology (Berl).
1990; 100(2): 275-80.
126:
Zarrindast MR, Moghaddampour E.
Opposing
influences of D-1 and D-2 dopamine receptors activation
on morphine-induced antinociception.
Arch Int Pharmacodyn Ther.
1989 Jul-Aug; 300: 37-50.
127:
Zarrindast MR, Poursoltan M.
Interactions of
drugs acting on central dopamine receptors and
cholinoceptors on yawning responses in the rat induced
by apomorphine, bromocriptine or physostigmine.
Br J Pharmacol. 1989 Apr;
96(4): 843-8.
128:
Zarrindast MR, Mahmoudi M.
Bromocriptine-induced
hypothermia: D-2 receptor involvement.
Arch Int Pharmacodyn Ther.
1989 Mar-Apr; 298: 38-49.
129:
Zarrindast MR, Hosseini-Nia T, Allah-Maddadi S.
Food intake
suppressant effect of baclofen in rats.
Gen Pharmacol. 1989;
20(5): 701-3.
130:
Zarrindast MR, Dibayan M.
Involvement of
GABAA receptor sites in diazepam hypothermia.
Gen Pharmacol. 1989;
20(6): 855-9.
131:
Zarrindast MR, Djavdan M.
GABAA-antagonists and baclofen analgesia.
Gen Pharmacol. 1988;
19(5): 703-6.
132:
Zarrindast MR, Hosseini-Nia T.
Anorectic and behavioural effects of bupropion.
Gen Pharmacol. 1988;
19(2): 201-4.
133:
Zarrindast MR, Oveissi Y.
GABAA and GABAB
receptor sites involvement in rat thermoregulation.
Gen Pharmacol. 1988;
19(2): 223-6.
134:
Zarrindast MR, Hosseini-Nia T, Farnoodi F.
Anorectic effect of ephedrine.
Gen Pharmacol. 1987;
18(5): 559-61.
135:
Amini-Sereshki L, Zarrindast MR.
Brain stem tonic
inhibition of thermoregulation in the rat.
Am J Physiol. 1984 Jul;
247(1 Pt 2): R154-9.
136:
Zarrindast MR.
Sympathomimetic
activity of mazindol on rat anococcygeus muscle and vas
deferens. Arch Int
Pharmacodyn Ther. 1984 Feb; 267(2): 258-63.
137:
Zarrindast MR.
Dopamine-like properties of ephedrine in rat
brain. Br J Pharmacol.
1981 Sep; 74(1): 119-22.
138:
Dehpour AR, Khoyi MA, Koutcheki H, Zarrindast MR.
Pharmacological study of the anococcygeus muscle
of the dog.
Br J Pharmacol. 1980;
71(1): 35-40.
139:
Dehpour AR, Khoyi MA, Pousti A, Seify A, Zarrindast MR.
Release of
[3H]-noradrenaline from the guinea-pig vas deferns by
ethacrynic acid [proceedings]
Br J Pharmacol. 1980 Jan;
68(1): 135P.
140:
Dehpour AR, Khoyi MA, Koutcheki H, Zarrindast MR.
Pharmacological
study of the anococcygeus muscle of the dog
[proceedings] Br J
Pharmacol. 1978 Nov; 64(3): 452P.
141:
Djahanguiri B, Zarrindast MR, Gerayesh-Nejad S.
Effects of cold or restraint on incidence of
gastric ulceration induced in rats by ulcerogenic drugs.
Eur J Pharmacol. 1978 Sep
1; 51(1): 77-9.
142:
Kruk ZL, Zarrindast MR.
Effects of
morphine on uptake and release of dopamine in mouse and
rat striatal synaptosomes [proceedings]
Br J Pharmacol. 1978 Jun;
63(2): 386P.
143:
Khoyi MA, Pousti A, Powis G, Zarrindast MR.
Tachyphylaxis to
ethacrynic acid in the isolated atrium of guinea-pig and
its relation to noradrenaline stores.
Br J Pharmacol. 1978 May;
63(1): 191-6.
144:
Zarrindast MR, Sharghi G, Gerayesh-Nejad S, Djahanguiri
B.
Cyclic AMP and
cyclic GMP levels in glandular stomach of restrained
rats. Res Commun Chem
Pathol Pharmacol. 1977 Oct; 18(2): 373-6.
145:
Kruk ZL, Smith LA, Zarrindast MR.
Antagonism of
responses to anorectics by selective receptor blockers
[proceedings]. Br J
Pharmacol. 1976 Nov; 58(3): 468P-469P.
146:
Kruk ZL, Zarrindast MR.
Mazindol anorexia is mediated by activation of
dopaminergic mechanisms.
Br J Pharmacol. 1976 Nov;
58(3): 367-72.
147:
Kruk ZL, Zarrindast MR.
The effects of
anorectic drugs on uptake and release of brain
monoamines [proceedings].
Br J Pharmacol. 1976 Oct; 58(2): 272P-273P. No abstract
available.
148:
Sadeghi D, Zarrindast MR, Ghaffarpur FA.
Prevention of
promethazine-induced gastric ulcers in guinea pigs with
disodium cromoglycate.
Toxicol Appl Pharmacol. 1976 Jan; 35(1): 179-81.
149:
Lalezari I, Shafiee A, Badaly A, Salimi MM, Khoyi MA,
Abtahi F, Zarrindast MR.
Synthesis and
pharmacological activity of 5-substituted
2-(N,N-dialkylaminoethyl)amino- and
2-N-methylpiperazinyl-1,3,4-thiadiazoles.
J Pharm Sci. 1975 Jul;
64(7): 1250-2.
150:
Khoyi MA, Pousti A, Zarrindast MR.
The effect of ethacrynic acid on the guinea-pig and
rat isolated vas deferens.
Br J Pharmacol. 1974 Dec;
52(4): 579-84. No abstract available.
151:
Sadeghi D, Zarrindast MR, Abtahi F.
Effect of
acylphenothiazine, SKF 17,910-A on gastric mucosa in
rats.
Isr J Med Sci. 1974 May;
10(5): 534-6. No abstract available.
Effect of ethacrynic acid on spontaneous contractions of
isolated guinea-pig atria.
Eur J Pharmacol. 1973
Jun; 22(3): 351-4. No abstract available.
153:
Djahanguiri B, Hemmati M, Zarrindast MR.
Prevention by disulfiram of restraint- and indomethacin-induced
gastric mucosal ulceration in rats.
Isr J Med Sci. 1973 May;
9(5): 662-3. No abstract available.
Publication which are not in Pubmed:
Shafiezadeh, M.,
Zarrindasst, M.R., Fatollahi, Y.,
Semnanian, S. (2000) Influences of different
adrenoceptor agonists and antagonists on
amphetamine-induced climbing in mice. Med. J. of IR of
Iran 14, 283-287.
Zarrindast, M.R. Rezayat, M. Zolfagharipour, M.R.
(2000) Effects of CCK receptor agonists and antagonists
on morphine-induced antinociception in mice. Med. J. IR
of Iran. 14, 261-266.
Sadeghipour, G.R., Yousefi, R., Hejeri, S., Abassian,
A.R., Zarrindast, M.R. (2000) Effect of Low level
helium-neon laseron isoniazid-induced hyperglycemia in
mice. Arch. Irn. Med. 3, 85-87.
Zarrindast, M.R. ,B. Hashemi and V.
Tolui (2000) Effects of
dopamine receptor agonistsand antagonists on baclofen-induced
antinociception in formalin test. Med. J. I.R.I. (in
press)
Fakhraee, A.H., Mazandarany, H.H., Zarrindast, M.R.
(2000) Analgesic effect of codeine plus bromocriptine
during simple teeth extraction and minor oral soft
tissue surgery. Arch. Iranian Med. 3, 10-14.
Rezayat M., Ghazi-Khansari M., Moustafavi-Mehr B.,
Zarrindast M.R. (2000) Effects ofcholecystokinin
receptor on morphine-induced morphine- and
cocaine-induced hypothermia. Med. J. IRI, 14, 151-154.
Rezayat M., Hosseini H., Akhondian J., Vahdati N.,
Zarrindast M.R. (1999) Influences of CCK receptor
agonist and antagonists on tolerance induced to anti-pnetylentetrazole
activity of diazepam. Med. J. I.R.I. 12, 365-369
Rezayat, M., H. Hosseini, J. Akhodian, N. Vahedi and
M.R. Zarrindast (1999) Influence of CCK receptor
agonist and antagonists on tolerance induced to
antipentylenetetrazol activity of diazepam. Med. J.
I.R.I. 12: 365-369.
